David Tyas
Bristol, ENG UB81DH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Nivolumab in gastric/gastroesophageal junction cancer: real-world data from UK Early Access to Medicines Scheme.
Journal: Future oncology (London, England)
Published: June 08, 2021
Consistency of recording of chemotherapy cycles in the National Cancer Registration and Analysis Service Systemic Anti-Cancer Therapy database and the Hospital Episode Statistics Admitted Patient Care database.
Journal: Future oncology (London, England)
Published: December 11, 2019
Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: November 15, 2019
A Review of Survival Analysis Methods Used in NICE Technology Appraisals of Cancer Treatments: Consistency, Limitations, and Areas for Improvement.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: November 12, 2019
Early Access to Medicines Scheme: real-world data collection.
Journal: Drug discovery today
Published: April 10, 2019
Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma.
Journal: Journal of medical economics
Published: January 15, 2019
Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: March 23, 2018
Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation.
Journal: PharmacoEconomics
Published: September 04, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026